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Many genes are repressed during mitosis, and this is
known to involve differential phosphorylation of spe-
cific factors required for transcription, 3′-end RNA
processing and translation. A recent study suggests
that splicing is also targeted for mitotic repression,
in this case by dephosphorylation of the newly iden-
tified splicing factor SRp38.
During the past two decades great strides have been
made in elucidating many of the molecular controls
that underlie progression through the cell cycle.
Perhaps not surprising for a process that requires
such drastic reprogramming of cell architecture, a
major transition that occurs during mitosis is the arrest
of much of the gene expression that is active during
interphase. Transcription, polyadenylation and trans-
lation are all known to be targets for this mitotic inhi-
bition, in each case by a change in the phospho-
rylation status of one or more factors required for
these processes [1–5]. Shin and Manley [6] have now
reported evidence that pre-mRNA splicing is also a
target for mitotic inhibition. The mitosis-regulated
dephosphorylation of SRp38, a recently identified
member of the SR family of splicing factors, appears
to be involved in this inhibition. This study contributes
interesting and important new information relevant to
cell-cycle control, and also raises intriguing questions
as to the mechanisms and specificity of regulation of
splicing during the cell cycle. 
Numerous earlier studies have established connec-
tions between pre-mRNA splicing and the cell cycle
(reviewed in [7]). For example, conditional mutations in
several splicing factors in yeast cause cell-cycle arrest
at the restrictive temperature, although in most cases it
was not clear whether the effects were direct or indi-
rect. In one recent study [8], however, it was shown that
cell-cycle arrest at the G2/M transition in the budding
yeast Saccharomyces cerevisiae, as a result of a tem-
perature-sensitive mutation in the conserved spliceo-
some-associated protein Cef1p, could be partially
suppressed by the deletion of the intron in the α tubulin
gene. So in this case, and probably many others involv-
ing genetic defects in splicing components that impact
on the cell cycle, the arrest most likely is indirect,
caused by the disruption of the splicing of one or more
pre-mRNAs required for cell-cycle progression. 
Other studies have indicated a link between the
mammalian kinase SRPK1 and its homologs in other
species — Dsk1 in the fission yeast Schizosaccha-
romyces pombe and Sky1 in S. cerevisiae — and the
cell cycle. Dsk1 was first identified as a kinase that,
when overproduced, prevents cell-cycle progression
[9]. SRPK1 was isolated as a kinase that is upregu-
lated during mitosis and induces the disassembly of
splicing-factor-rich nuclear ‘speckles’ (also referred to
as interchromatin granule clusters) [10] (Figure 1).
SRPK1 and its homologs were subsequently shown to
phosphorylate serine and threonine residues within
the RS (rich in alternating arginine and serine residues)
domains of splicing factors, including members of the
SR family [11]. RS domains mediate protein–protein
interactions with other RS domains, and these inter-
actions are important for the assembly of multisubunit
complexes required for both constitutive and regu-
lated splicing (reviewed in [12]). From previous work
on SRPK1, and from the more recent work on SRp38
described below [6], differential phosphorylation of RS
domains appears to be important for one or more
aspects of splicing regulation during the cell cycle.
SR family splicing factors have a similar domain
organization, with one or two amino-terminal RNA
recognition motifs (RRMs) and a carboxy-terminal RS
domain (reviewed in [12]). Members of this family iden-
tified earlier also have several common functional
properties: for example, each can activate splicing
when added to in vitro reactions in a cytoplasmic
S100 extract (which contains all the components
necessary for splicing activity except for SR family
proteins and other RS domain splicing factors).
Although SRp38 has a similar domain organization
(Figure 2A), it does not have the activator function of
other family members: when recombinant SRp38 was
added to splicing reactions, surprisingly it was found
to inhibit pre-mRNA splicing [6,13]. 
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Figure 1. Redistribution of spliceosomal components during
mitosis. 
(A) Confocal microscope image of an interphase human CaSki
cell double-immunolabeled with antisera specific for SRm160
(red) and SRm300 (green), two RS domain proteins associated
with spliceosomes. Both proteins concentrate in splicing
factor-rich nuclear speckles during interphase; regions of
overlap between the two proteins are indicated (yellow). (B)
During mitosis nuclear speckle structures disassemble and
many splicing factors, such as SRm300, disperse and/or con-
centrate in mitotic interchromatin granules. The confocal image
shows a single CaSki cell at metaphase, double immunolabeled
with anti-SRm300 (green) and anti-tubulin (red) antibodies.
Bar = 5µm. (Images reproduced from [14].)
Shin and Manley [6] noted that SRp38 migrates in
cell extracts as a doublet. As the RS domains of SR
proteins are known to be phosphorylated by kinases
such as SRPK1, it was suspected that the lower form
of the protein corresponded to dephosphorylated
SRp38 (dSRp38). This was confirmed by phosphatase
treatment, which converted all of the SRp38 in the
extract to the lower-migrating form. Strikingly, it was
found that preparations of dSRp38 protein were
approximately 50-fold more active at inhibiting splic-
ing than preparations consisting predominantly of the
phosphorylated form of the protein. 
SRp38 thus appears to be unusual among SR family
proteins in that it acts as a splicing repressor, trig-
gered by dephosphorylation by an as yet unidentified
phosphatase. Although the mechanism by which
dSRp38 causes splicing inhibition is not clear, it was
observed that dSRp38 does not interact stably with
other SR proteins, arguing against a model in which it
prevents splicing by direct disruption of interactions
involving SR proteins that function in splicing. Addi-
tion of the protein to splicing reactions was, however,
observed to prevent the formation of early splicing
complexes containing the spliceosome component U2
snRNP (which binds to the intron branch-point region
of the pre-mRNA splicing substrate), a step in spliceo-
some assembly which normally requires SR proteins
[6] (see Figure 2B).
Shin and Manley [6] conjectured that one step at
which dephosphorylation of SRp38 might play an
important regulatory role is mitosis, given the prece-
dent that other steps in gene expression are inacti-
vated by a change in phosphorylation status of one or
more critical components. To investigate this possi-
bility, they initially compared the phosphorylation
status of SRp38 at different stages during the cell
cycle, using extracts from cells synchronized after
release from a double-thymidine block: higher levels
of dSRp38 were detected as cells entered mitosis.
Shin and Manley [6] next performed an elegant
series of experiments to test whether splicing, like
other steps in gene expression, is blocked at mitosis,
and also whether dSRp38 might be involved in such
a block. They prepared whole-cell extracts using
three different salt extraction conditions — 0.3M,
0.6M and 2.0M — from cells grown asynchronously
(AE) or after mitotic arrest (ME). When these three
extracts were tested for splicing activity, both the AE
and ME prepared using 0.3M salt were active; but
splicing was specifically and increasingly inhibited in
the ME when the extractions were performed at the
higher salt concentrations. Remarkably, this inhibition
correlated perfectly with the increased presence 
of dSRp38 in the ME, which was only released from
the insoluble fraction of the extracts at the elevated
salt concentrations. 
To test whether dSRp38 might be responsible for
the ME block, Shin and Manley [6] depleted most of
the protein by using avidin beads coupled to an RNA
fragment selected to bind with high affinity to the RRM
of SRp38. Strikingly, they found that splicing was
activated in the 2M salt-extracted ME depleted of
SRp38. Moreover, splicing inhibition was restored to
this depleted extract by addition of dSRp38, but not
by SRp38 or the SR family protein ASF/SF2. 
Aside from the issue of whether these results reflect
a physiologically important mechanism for mitotic inhi-
bition of splicing, which was not addressed by Shin
and Manley [6], there are some aspects of the results
that bear consideration for future studies in this area.
In particular, while dSRp38 may appear to be unique in
its ability to prevent splicing in vitro, the results do not
in any way exclude the possibility that other splicing
factors, especially those with RS domains, are also
targets for splicing regulation during the cell cycle. 
First, there is the issue of functional redundancy
among SR proteins to consider (reviewed in [12]).
Previous studies found that depletion of individual RS
domain proteins can prevent splicing of different pre-
mRNA substrates, but addition to the depleted extracts
of SR proteins other than the specifically depleted com-
ponent can often restore splicing activity. This is most
likely because SR proteins, at endogenous levels, func-
tion by forming multiple weak, cooperative interactions
which are required to assemble splicing complexes.
Specific depletion of any one factor contributing to
such interactions may be sufficient to prevent splicing;
but addition of excess levels of any of a number of SR
proteins may be sufficient to restore activity, because
of the redundant nature of the interactions that can
form at elevated levels of these proteins. 
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Figure 2. Mitotic inhibition of splicing by dSRp38.
(A) Domain structure of SRp38. Like other SR proteins, SRp38
contains an amino-terminal RNA recognition motif (RRM) and a
phosphorylated carboxy-terminal alternating arginine/serine-
rich (RS) domain. (B) An unidentified phosphatase that is acti-
vated during mitosis dephosphorylates SRp38, generating the
dephosphorylated form dSRp38 which inhibits splicing at an
early step, prior to the formation of a pre-spliceosomal complex
containing U2 snRNP [6]. 5′ ss, 5′ splice site; 3′ ss, 3′ splice site;
bs, branch site.
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The situation with dSRp38 may be similar: at
endogenous concentrations, it may repress splicing in
the context of weak, cooperative interactions that are
lost when it is depleted. But other RS domain proteins,
which may also have an altered phosphorylation
status at mitotis, might also be able to repress splic-
ing. Although Shin and Manley [6] did not detect sub-
stantial changes in the phosphorylation status of other
SR proteins in mitotic-phase extracts, the monoclonal
antibody they used (mAb104) may simply fail to detect
many other RS domain proteins, several of which 
are candidates for having cell-cycle-associated func-
tions [14,15]. Moreover, SRp38 is not ubiquitously
expressed [6], suggesting that there are other factors
which suppress splicing during mitosis in the tissues
that lack SRp38. 
A related issue is the unresolved role of SRPK1 and
its homologs during the cell cycle. Earlier work sug-
gested that SRPK1 and its S. pombe homolog Dsk1
might participate in mitosis [9,10]. While the phos-
phatase which targets SRp38 during mitosis is not
known, it is interesting to consider that it might act on
serine and threonine resides in the RS domain of the
protein and that SRPK1 and/or related kinases might
function to regenerate phosphorylation of dSRp38,
and possibly other RS domain proteins, and thereby
allow a return to interphase splicing patterns upon exit
from mitosis.
There also remains the more general question of
why splicing is inhibited during the cell cycle,
particularly given that three other steps in gene
regulation are targeted for mitotic inhibition. One pos-
sibility is that blocking gene expression at multiple
levels ensures limited competition for cell-cycle-
specific functions. Although splicing inhibition during
mitosis might be largely redundant with these other
blocks, it may nevertheless be important to ensure
that processed transcripts that are not required, or
which might inhibit cell-cycle progression, are not
made. Sequestration of unprocessed transcripts in
mitotic complexes by factors such as dSRp38 might
facilitate such a block. These transcripts might then
be available for rapid expression following release of
the block during exit from mitosis.
Related to these issues is the question of the extent
of splicing regulation during different stages of the cell
cycle. For example, it will be important to determine
which changes in alternative splicing regulation, in
addition to transcriptional control, are required for cell-
cycle progression. Clearly, much work needs to be
done to elucidate the nature of the molecular
mechanisms which function to regulate splicing as well
as other steps in gene expression during the cell cycle.
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